Ellicott City, MD, United States of America

Christopher D Gocke

USPTO Granted Patents = 25 



Average Co-Inventor Count = 2.2

ph-index = 18

Forward Citations = 1,181(Granted Patents)


Location History:

  • Hummelstown, PA (US) (2000 - 2003)
  • Elliott City, MD (US) (2003 - 2011)
  • Elliot City, MD (US) (2011)
  • Ellicott City, MD (US) (2003 - 2013)

Company Filing History:


Years Active: 2000-2013

Loading Chart...
Loading Chart...
Loading Chart...
25 patents (USPTO):Explore Patents

Title: Christopher D. Gocke: Innovator in Tumor-Associated Nucleic Acid Detection

Introduction

Christopher D. Gocke is an accomplished inventor based in Ellicott City, MD, recognized for his significant contributions to the field of cancer diagnostics. With a portfolio of 25 patents, Gocke has pioneered methods to detect tumor-associated DNA in plasma or serum, providing vital tools for diagnosing and monitoring various neoplastic conditions.

Latest Patents

Gocke's latest innovations include a groundbreaking method for detecting tumor-associated DNA in plasma or serum, specifically aimed at identifying extracellular nucleic acids that correlate with malignancies. This invention comprises the detection of mutant oncogenes and other tumor-related DNA, utilizing advanced techniques like rapid DNA extraction coupled with nucleic acid amplification. This pioneering method enables the early identification of cancers, including colorectal, pancreatic, lung, breast, bladder, and ovarian malignancies, and aids in monitoring the clinical status of patients with neoplastic disorders.

Career Highlights

Over the years, Christopher D. Gocke has worked with prominent organizations, including the Penn State Research Foundation and Oncomedx, Inc. His research and inventions have proven instrumental in advancing cancer diagnostics, ensuring better patient outcomes through early and accurate detection methods.

Collaborations

Throughout his career, Gocke has collaborated with notable colleagues such as Michael S. Kopreski and Floyd A. Benko. These partnerships have facilitated the development of innovative technologies geared towards improving cancer detection and treatment monitoring.

Conclusion

Christopher D. Gocke's work exemplifies the essential role of innovation in enhancing cancer diagnostics. Through his extensive patent portfolio and collaborative efforts, he continues to contribute significantly to the field, paving the way for improved methodologies in detecting and managing neoplastic diseases. His inventions underscore the importance of early detection in the fight against cancer, showcasing the impact of research and innovation in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…